Neurotransmitter levels in the brain can indicate brain health and neurodegenerative diseases like Alzheimer’s.
Vyne aims to raise $88M; Sanofi invests in gene therapy company; 4DMT addresses clinical hold
Plus, news about United Therapeutics and Moderna: Immuno-inflammation biotech’s $88M: Vyne Therapeutics announced an $88 million private placement to, in part, help fund a Phase